Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724838 | SCV000331986 | uncertain significance | not provided | 2015-06-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724838 | SCV000514250 | likely benign | not provided | 2020-10-08 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000394979 | SCV000596534 | likely benign | not specified | 2015-12-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001085734 | SCV000769982 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2K; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1; Walker-Warburg congenital muscular dystrophy | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000724838 | SCV001145176 | benign | not provided | 2019-06-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000724838 | SCV001502105 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | POMT1: BP4, BP7, BS2 |
Prevention |
RCV004542979 | SCV004761864 | likely benign | POMT1-related disorder | 2022-04-27 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory of Diagnostic Genome Analysis, |
RCV000724838 | SCV002036715 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000724838 | SCV002037664 | likely benign | not provided | no assertion criteria provided | clinical testing |